The effects of antiplatelet agents on platelet-leukocyte aggregations in patients with acute cerebral infarction

Journal of Thrombosis and Thrombolysis

Volumn 27, Issue 2, 2009, Pages 233-238

  Cao, Yong Jun ^a   Wang, Yin Ming ^a   Zhang, Jing ^b   Zeng, Yan Jun ^c   Liu, Chun Feng ^a  

^a THE SECOND AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c BEIJING UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

Aspirin; Cerebral infarction; Clopidogrel; Platelet leukocyte aggregations

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CLOPIDOGREL; PADGEM PROTEIN;

ACUTE DISEASE; ADULT; AGED; ARTICLE; BRAIN INFARCTION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFICACY; FEMALE; FLOW CYTOMETRY; HUMAN; LEUKOCYTE AGGREGATION; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SENSITIVITY ANALYSIS; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE AGGREGATION INHIBITION;

AGED; ASPIRIN; BLOOD PLATELETS; CELL ADHESION; CEREBRAL INFARCTION; FEMALE; HUMANS; LEUKOCYTES; MALE; MIDDLE AGED; PLATELET ACTIVATION; PLATELET AGGREGATION INHIBITORS; TICLOPIDINE;

EID: 62149106688     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11239-007-0190-x     Document Type: Article

References (30)

1. Dougherty JH Jr, Levy DE, Weksler BB (1977) Platelet activation in acute cerebral ischaemia. Serial measurements of platelet function in cerebrovascular disease. Lancet 1:821-824
2. Iwamoto T, Kubo H, Takasaki M (1995) Platelet activation in the cerebral circulation in different subtypes of ischemic stroke and Binswanger's disease. Stroke 26:52-56
3. McConnell JP, Cheryk LA, Durocher A, Bruno A, Bang NU, Fleck JD, Williams L, Biller J, Meschia JF (2001) Urinary 11-dehydro-thromboxane B(2) and coagulation activation markers measured within 24 h of human acute ischemic stroke. Neurosci. Lett. 313:88-92
4. McCabe DJ, Harrison P, Mackie IJ, Sidhu PS, Purdy G, Lawrie AS, Watt H, Brown MM, Machin SJ (2004) Platelet degranulation and monocyte-platelet complex formation are increased in the acute and convalescent phases after ischaemic stroke or transient ischaemic attack. Br J Haematol 125(6):777-787
5. Kurabayashi H, Tamura J, Naruse T, Kubota K (2000) Possible existence of platelet activation before the onset of cerebral infarction. Atherosclerosis 153(1):203-207
6. Grau AJ, Ruf A, Vogt A, Lichy C, Buggle F, Patscheke H, Hacke W (1998) Increased fraction of circulating activated platelets in acute and previous cerebrovascular ischemia. Thromb Haemost 80:298-301
7. Grau AJ, Reiners S, Lichy C, Buggle F, Ruf A (2003) Platelet function under aspirin, clopidogrel, and both after ischemic stroke: A case-crossover study. Stroke 34:849-854
8. Ray MJ, Walters DL, Bett JN, Cameron J, Wood P, Aroney CN (2005) Platelet-monocyte aggregates predict troponin rise after percutaneous coronary intervention and are inhibited by Abciximab. Int J Cardi 101:249-255
9. Gurbel PA, Galbut B, Bliden KP, Bahr RD, Roe MT, Serebruany VL et al (2002) Effect of eptifibatide for acute coronary syndromes: Rapid versus late administration-therapeutic yield on platelets. J Thromb Thrombol 14:213-219
10. Michelson AD, Barnard MR, Krueger LA, Valeri CR, Furman MI (2001) Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface p-selectin:sTudies in baboons, human coronary intervention,and human acute myocardial infarction. Circulation 104:1533-1537
11. Maugeri N, Santarelli MT, Lazzari MA (2000) Circulating platelet/ polymorphonuclear leukocyte mixed-cell aggregates in patients with mechanical heart valve replacement. Am J Hematol 65:93-98
12. Hilberg T, Schmidt V, Glaser D, Schammne D, Losche W, Gabriel HH (2002) Platelet activity, sensitivity to agonist, and platelet-leukocyte conjugate formation after long-term exercise. Platelets 13:273-277
13. Klinkhardt U, Bauersachs R, Adams R et al (2003) Clopidogrel but not aspirin reduces P-selectin expression and formation of platelet-leukocyte aggregates in patients with atherosclerotic vascular disease. Clin Pharmacol Ther 73(3):232-241
14. Irving PM, Macey MG, Shah U, Webb L, Langmead L, Rampton DS (2004) Formation of platelet-leukocyte aggregates in inflammatory bowel disease. Inflamm Bowel Dis 10:361-372
15. Ogura H, Kawasaki T, Tanaka H, Koh T, Tanaka R, Ozeki Y et al (2001) Activated platelets enhance microparticle formation and platelet-leukocyte interaction in severe trauma and sepsis. J Trauma 50:801-809
16. Mirlashari MR, Haberg IA, Lyberg T (2002) Platelet-platelet and platelet-leukocyte interactions induced by outer membrane vesicles from N. meningitidis. Platelets 13:91-99
17. Peters MJ, Heyderman RS, Faust S, Dixon GLJ, Inwald DP, Klein NJ et al (2003) Severe meningococcal disease is characterized by early neutrophil but not platelet activation and increased formation and consumption of platelet-neutrophil complexes. J Leukoc Biol 73:722-730
18. Chinese Neurological Association, Chinese Neurosurgical Association (1996) Diagnosis on crebrovascular diseases. Chin J Neurol 29:379-381
19. 2 integrin. Circulation 98:873-882
20. Merten M, Beythien C, Gutensohn K, Kühnl P, Meinertz T, Thiagarajan P (2005) Sulfatides activate platelets through p-selectin and enhance platelet and platelet-leukocyte aggregation. Arterioscler Thromb Vasc Biol 25:258-263
21. Yinming W, Chunfeng L (2005) Platelet-leukocyte aggregations and antiplatelet therapy. Cerebrovasc Dis Foreign Med Sci 13:348-351
22. Kozek-Langenecker SA, Spiss CK, Michalek-Sauberer A, Felfernig M, Zimpfer M (2003) Effect of prostacyclin on platelets, polymorphonuclear cells, and heterotypic cell aggregation during hemofiltration. Crit Care Med 31:864-868
23. Giesen PLA, Rauch U, Bohrmann B, Kling D, Roqué M, Fallon JT et al (1999) Blood-borne tissue factor: Another view of thrombosis. PNAS 96:2311-2315
24. Gurbel PA, Galbut B, Bliden KP, Bahr RD, Roe MT, Serebruany VL et al (2002) Effect of eptifibatide for acute coronary syndromes: Rapid versus late administration-therapeutic yield on platelets. J Thromb Thrombol 14:213-219
25. Evangelista V, Celardo A, Dell'Elba G, Manarini S, Mironov A, de Gaetano G et al (1999) Platelet contribution to leukotriene production in inflammation: In vivo evidence in the rabbit. Thromb Haemost 81:442-448
26. Huo Y, Schober A, Forlow SB, Smith DF, Hyman MC, Jung S et al (2003) Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Nat Med 9:61-67
27. Li N, Hu H, Lindqvist M, Wikström-Jonsson E, Goodall AH, Hjemdahl P et al (2000) Platelet-leukocyte cross talk in whole blood. Arterioscler Thromb Vasc Biol 20:2702-2708
28. Sarma J, Laan CA, Alam S, Jha A, Fox KAA, Dransfield I et al (2002) Increased platelet binding to circulating monocytes in acute coronary syndromes. Circulation 105:2166-2171
29. Klinkhardt U, Kuczka K, Harder S (2003) Effects of the NHE-1 inhibitor cariporide alone or together with the P2Y12 antagonist AR-C69331 MX on CD62P expression and formation of platelet-leukocyte aggregates. Thromb Res 111:251-257
30. Hagberg IA, Lyberg T (2000) Evaluation of circulating platelet-leukocyte conjugates: A sensitive flow cytometric assay well suited for clinical studies. Platelets 11:151-160